Cyproterone-induced hepatotoxicity.

Suppr

超能文献

作者信息

Pinganaud G, Chaslerie A, Bourdel Marchasson I, Decamps A, Manciet G, Emeriau J P

出版信息

Ann Pharmacother. 1995 Jun;29(6):634. doi: 10.1177/106002809502900619.

DOI:10.1177/106002809502900619

PMID:7663042

Abstract

摘要

相似文献

Cyproterone-induced hepatotoxicity.

Ann Pharmacother. 1995 Jun;29(6):634. doi: 10.1177/106002809502900619.

[Severe acute hepatitis due to cyproterone].

Gastroenterol Hepatol. 1997 Aug-Sep;20(7):385.

[Fatal subfulminant hepatitis caused by cyproterone acetate].

Gastroenterol Clin Biol. 1991;15(10):772-3.

Severe hepatocellular dysfunction following cyproterone acetate therapy.

Br J Urol. 1991 Mar;67(3):312-3. doi: 10.1111/j.1464-410x.1991.tb15142.x.

Hepatitis due to cyproterone acetate.

Eur J Cancer. 1992;28A(11):1931-2. doi: 10.1016/0959-8049(92)90041-y.

Severe hepatitis caused by cyproterone acetate.

Gut. 1990 May;31(5):556-7. doi: 10.1136/gut.31.5.556.

[Hepatitis after treatment with cyproterone acetate. Apropos of a case].

J Urol (Paris). 1990;96(3):169-71.

[Hepatotoxicity of cyproterone acetate].

Rev Med Interne. 1992 May-Jun;13(3):245. doi: 10.1016/s0248-8663(05)81339-6.

Acute hepatitis induced by cyproterone acetate.

Ann Pharmacother. 2001 Sep;35(9):1053-5. doi: 10.1177/106002800103500902.

Experience in the treatment of prostatic carcinoma with cyproterone acetate.

J Urol. 1973 Jan;109(1):68-70. doi: 10.1016/s0022-5347(17)60352-5.

引用本文的文献

Dose adaptation of antineoplastic drugs in patients with liver disease.

Drug Saf. 2006;29(6):509-22. doi: 10.2165/00002018-200629060-00004.

Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer.

Curr Treat Options Oncol. 2003 Oct;4(5):351-62. doi: 10.1007/s11864-003-0036-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cyproterone-induced hepatotoxicity.

Ann Pharmacother. 1995 Jun;29(6):634. doi: 10.1177/106002809502900619.

[Severe acute hepatitis due to cyproterone].

Gastroenterol Hepatol. 1997 Aug-Sep;20(7):385.

[Fatal subfulminant hepatitis caused by cyproterone acetate].

Gastroenterol Clin Biol. 1991;15(10):772-3.

Severe hepatocellular dysfunction following cyproterone acetate therapy.

Br J Urol. 1991 Mar;67(3):312-3. doi: 10.1111/j.1464-410x.1991.tb15142.x.

Hepatitis due to cyproterone acetate.

Eur J Cancer. 1992;28A(11):1931-2. doi: 10.1016/0959-8049(92)90041-y.

Severe hepatitis caused by cyproterone acetate.

Gut. 1990 May;31(5):556-7. doi: 10.1136/gut.31.5.556.

[Hepatitis after treatment with cyproterone acetate. Apropos of a case].

J Urol (Paris). 1990;96(3):169-71.

[Hepatotoxicity of cyproterone acetate].

Rev Med Interne. 1992 May-Jun;13(3):245. doi: 10.1016/s0248-8663(05)81339-6.

Acute hepatitis induced by cyproterone acetate.

Ann Pharmacother. 2001 Sep;35(9):1053-5. doi: 10.1177/106002800103500902.

Experience in the treatment of prostatic carcinoma with cyproterone acetate.

J Urol. 1973 Jan;109(1):68-70. doi: 10.1016/s0022-5347(17)60352-5.

引用本文的文献

Dose adaptation of antineoplastic drugs in patients with liver disease.

Drug Saf. 2006;29(6):509-22. doi: 10.2165/00002018-200629060-00004.

Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer.

Curr Treat Options Oncol. 2003 Oct;4(5):351-62. doi: 10.1007/s11864-003-0036-5.